×
About 3,816 results

ALLMedicine™ Hypoparathyroidism Center

Research & Reviews  1,673 results

Rare genetic mutation triggering acute liver failure in a toddler requiring a liver tra...
https://doi.org/10.1111/petr.14048
Pediatric Transplantation; Chen CB, Mistry Ambani N et. al.

Jun 2nd, 2021 - APS-1 is an extremely rare, autosomal recessive condition that often presents with candidiasis, adrenal insufficiency, and hypoparathyroidism. This condition is associated with autoimmune hepatitis in less than 20% of cases, and there have only be...

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
https://doi.org/10.1007/s40618-021-01585-6 10.1056/NEJM199006283222601 10.1016/S1571-5078(07)00212-7 10.1056/NEJMra1713301 10.1016/j.autrev.2017.11.012 10.1136/jmg.29.11.824 10.1210/jc.2006-1873 10.1111/j.1399-0004.2006.00690.x 10.1515/JPEM.2006.19.11.1343 10.1016/j.lpm.2012.10.005 10.1515/JPEM.2004.17.6.917 10.1210/edrv.23.3.0466 10.1111/j.1365-2796.2009.02090.x 10.1590/S0004-27302012000100009 10.1016/j.autrev.2010.08.019 10.1016/j.coi.2016.07.003 10.1111/imm.12831 10.1111/j.1365-2265.2008.03318.x 10.3389/fimmu.2013.00331 10.1086/302145 10.1007/s004390050891 10.1210/jcem.83.4.4682 10.1002/humu.1178 10.1530/EJE-08-0328 10.1530/EJE-07-0843 10.1111/j.1365-2265.2009.03740.x 10.1210/jc.2017-00139 10.1530/EC-17-0022 10.1016/j.clim.2018.09.012 10.1007/s004390050846 10.1210/mend.12.8.0143 10.1530/eje.0.1430497 10.1210/jcem.86.10.7884 10.1210/jcem.87.2.8209 10.1210/jc.2002-021495 10.1007/BF03345295 10.1111/j.1365-2265.2008.03206.x 10.1007/s00431-007-0599-4 10.1016/j.clim.2010.12.021 10.1210/jc.2011-2461 10.1016/j.gene.2012.03.032 10.1159/000363537 10.1111/j.1365-2796.2009.02090.x 10.1111/j.1365-2265.2010.03862.x 10.1097/01.mpg.0000239739.09983.38 10.1056/NEJMoa0706487 10.3389/fendo.2018.00463 10.1182/asheducation-2017.1.181 10.1016/j.clml.2012.06.006 10.1016/S0025-6196(12)61377-9 10.1177/039463201002300331 10.1111/j.1365-2265.2008.03340.x 10.1530/EJE-08-0550 10.1210/clinem/dgaa140 10.1530/EJE-18-0313 10.1007/s40618-019-01079-6 10.1016/j.fertnstert.2005.04.060 10.1210/jc.2011-0414 10.1111/cei.12303 10.1210/jc.2012-2734 10.1016/j.clim.2015.03.012 10.1111/j.1749-6632.2002.tb02986.x 10.1001/jama.2019.21565 10.3390/ijms17071106 10.1002/humu.20224 10.1016/j.immuni.2015.04.021 10.1111/imm.12831
Journal of Endocrinological Investigation; Garelli S, Dalla Costa M et. al.

May 18th, 2021 - Autoimmune Polyglandular Syndrome type 1 (APS-1) is a rare recessive inherited disease, caused by AutoImmune Regulator (AIRE) gene mutations and characterized by three major manifestations: chronic mucocutaneous candidiasis (CMC), chronic hypopara...

Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome...
https://doi.org/10.1507/endocrj.EJ20-0717
Endocrine Journal; Iijima T, Jojima T et. al.

May 13th, 2021 - Chromosome 22q11.2 deletion syndrome is a multisystem genetic disorder that presents with hypocalcemia due to congenital hypoparathyroidism; cardiovascular, renal, and facial anomalies; and skeletal defects. This syndrome is also associated with a...

Clinical, immunological, and genetic features in 938 patients with autoimmune polyendoc...
https://doi.org/10.1080/1744666X.2021.1925543
Expert Review of Clinical Immunology; Sharifinejad N, Zaki-Dizaji M et. al.

May 7th, 2021 - Background: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a rare inborn immune error characterized by a triad of chronic mucocutaneous candidiasis (CMC), hypoparathyroidism (HP), and adrenal insufficiency (ADI).Methods...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, ...
https://doi.org/10.1089/thy.2017.0309
Thyroid : Official Journal of the American Thyroid Associ... Orloff LA, Wiseman SM et. al.

May 31st, 2018 - Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association...

Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian ...
https://doi.org/10.20945/2359-3997000000015
Archives of Endocrinology and Metabolism; Maeda SS, Moreira CA et. al.

Apr 25th, 2018 - Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e M...

European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyr...
https://doi.org/10.1530/EJE-15-0628
European Journal of Endocrinology; Bollerslev J, Rejnmark L et. al.

Jul 14th, 2015 - Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vit...

Clinical practice guideline: improving voice outcomes after thyroid surgery.
https://doi.org/10.1177/0194599813487301
Otolaryngology--head and Neck Surgery : Official Journal ... Chandrasekhar SS, Randolph GW et. al.

Jun 13th, 2013 - Thyroidectomy may be performed for clinical indications that include malignancy, benign nodules or cysts, suspicious findings on fine needle aspiration biopsy, dysphagia from cervical esophageal compression, or dyspnea from airway compression. Abo...

see more →

Drugs  123 results see all →

Clinicaltrials.gov  1,897 results

Ergocalciferol - ergocalciferol capsule, liquid filled-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2475e731-0072-4787-8a40-09137883c625

Jun 14th, 2021 - Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Vitamin d - ergocalciferol capsule-Aphena Pharma Solutions - Tennessee, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c0f4142-cc1f-43de-8677-ee06b6f4fc10

Jun 10th, 2021 - Ergocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Ergocalciferol - ergocalciferol capsule, liquid filled-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a80436e0-b507-4e7b-9a60-a9d5ddc4a045

Jun 8th, 2021 - Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Rare genetic mutation triggering acute liver failure in a toddler requiring a liver tra...
https://doi.org/10.1111/petr.14048
Pediatric Transplantation; Chen CB, Mistry Ambani N et. al.

Jun 2nd, 2021 - APS-1 is an extremely rare, autosomal recessive condition that often presents with candidiasis, adrenal insufficiency, and hypoparathyroidism. This condition is associated with autoimmune hepatitis in less than 20% of cases, and there have only be...

see more →

News  113 results

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.staging.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Drug Recall in US Causes Hypoparathyroid Patients Extreme Hardship
https://www.medscape.com/viewarticle/921971

Dec 1st, 2019 - The recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States over safety concerns about the product is gravely affecting the lives of American patients with severe hypoparathyroidism who need replacement PT...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.staging.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

see more →

Patient Education  5 results see all →